Efficacy and safety of fractional 1064‐nm picosecond laser for atrophic traumatic and surgical scars: A randomized, single‐blinded, split‐scar‐controlled study
Lasers in Surgery and Medicine · 2023-08 · 55 (6) · 536-546
DOI: 10.1002/lsm.23675 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 02.05.2023. Verfasst von Wareeporn Disphanurat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Dermatology, Thammasat University, Pathum Thani, Thailand. Hauptthemen laut MEDLINE: Acne Vulgaris, Lasers, Solid-State. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Objective
A fractional 1064‐nm picosecond laser is an efficient and safe treatment for atrophic acne scars. However, evidence of using a picosecond laser for atrophic posttraumatic and surgical scar therapy is lacking. This study aimed to evaluate the efficacy and safety of using a 1064‐nm picosecond laser with a microlens array (MLA) for the treatment of atrophic posttraumatic and surgical scars.
Methods
This was a prospective, intraindividual, single‐blinded, randomized split‐lesion‐controlled trial. Twenty‐five subjects with atrophic traumatic or surgical scars that existed for more than 1 year were enrolled. All atrophic scars were divided at the midline into two halves and randomly assigned to a treatment or control side. The treatment group was treated with a 1064‐nm picosecond laser with an MLA handpiece (spot size: 6–8 mm, fluence: 1.0–1.2 J/cm 2 , repetition rate: 5 Hz, three passes) for 3 monthly sessions. The scar volumes were objectively measured using a three‐dimensional (3D) photograph at baseline, 1 month after the first and second treatments, and 3 and 6 months after the final treatment. Subjective assessments were conducted by a blinded dermatologist and patients' self‐assessment to evaluate improvements at 3 months after the final treatment.
Results
The treated sides exhibited a significant volume reduction, with statistically significant improvements over the control group at 1 month after the first and second treatments and at 3 months after the final treatment ( p = 0.024, 0.005, and 0.019, respectively). At 3 months after the final treatment, a blinded dermatologist correctly identified the treated side in 24 of 25 patients (96%). The patients rated the improvements as excellent (>75%) and marked (50%–75%) in 36% and 48% of patients, respectively.
Conclusion
At 3 months, the 1064‐nm picosecond laser with a fractionated MLA can significantly reduce the posttraumatic and postsurgical atrophic scar volume in patients with Fitzpatrick skin types III‐V. Insufficient data preclude inferences regarding efficacy at 6 months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Dermatology, Thammasat University, Pathum Thani, Thailand.
- Department of Pathology and Forensic Medicine, Thammasat University, Pathumthani, Thailand.
ORCID-Profile: Wareeporn Disphanurat
Zitieren
APA
Disphanurat, W., Charutanan, N., Sitthiwatthanawong, P., & Suthiwartnarueput, W. (2023). Efficacy and safety of fractional 1064‐nm picosecond laser for atrophic traumatic and surgical scars: A randomized, single‐blinded, split‐scar‐controlled study. Lasers in Surgery and Medicine, 55(6), 536-546. https://doi.org/10.1002/lsm.23675
Vancouver
Disphanurat W, Charutanan N, Sitthiwatthanawong P, Suthiwartnarueput W. Efficacy and safety of fractional 1064‐nm picosecond laser for atrophic traumatic and surgical scars: A randomized, single‐blinded, split‐scar‐controlled study. Lasers in Surgery and Medicine. 2023;55(6):536-546. doi:10.1002/lsm.23675
BibTeX
@article{Disphanurat2023,
author = {Disphanurat, Wareeporn and Charutanan, Nipathorn and Sitthiwatthanawong, Pradtana and Suthiwartnarueput, Worapop},
title = {Efficacy and safety of fractional 1064‐nm picosecond laser for atrophic traumatic and surgical scars: A randomized, single‐blinded, split‐scar‐controlled study},
journal = {Lasers in Surgery and Medicine},
year = {2023},
volume = {55},
number = {6},
pages = {536--546},
doi = {10.1002/lsm.23675}
}
EUVIMED